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Abstract
The coat of Trypanosoma brucei consists mainly of glycosylphosphatidylinositol-anchored proteins that are present in
several million copies and are characteristic of defined stages of the life cycle. While these major components of the coats of
bloodstream forms and procyclic (insect midgut) forms are well characterised, very little is known about less abundant
stage-regulated surface proteins and their roles in infection and transmission. By creating epitope-tagged versions of
procyclic-specific surface antigen 2 (PSSA-2) we demonstrated that it is a membrane-spanning protein that is expressed by
several different life cycle stages in tsetse flies, but not by parasites in the mammalian bloodstream. In common with other
membrane-spanning proteins in T. brucei, PSSA-2 requires its cytoplasmic domain in order to exit the endoplasmic
reticulum. Correct localisation of PSSA-2 requires phosphorylation of a cytoplasmic threonine residue (T305), a modification
that depends on the presence of TbMAPK4. Mutation of T305 to alanine (T305A) has no effect on the localisation of the
protein in cells that express wild type PSSA-2. In contrast, this protein is largely intracellular when expressed in a null mutant
background. A variant with a T305D mutation gives strong surface expression in both the wild type and null mutant, but
slows growth of the cells, suggesting that it may function as a dominant negative mutant. The PSSA-2 null mutant exhibits
no perceptible phenotype in culture and is fully competent at establishing midgut infections in tsetse, but is defective in
colonising the salivary glands and the production of infectious metacyclic forms. Given the protein’s structure and the
effects of mutation of T305 on proliferation and localisation, we postulate that PSSA-2 might sense and transmit signals that
contribute to the parasite’s decision to divide, differentiate or migrate.
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Introduction
Throughout its digenetic life cycle in mammals and tsetse,
Trypanosoma brucei is covered by stage-specific coats of glycosylpho-
sphatidylinositol (GPI)-anchored molecules. The most abundant
components are present in several million copies per cell and are
expressed during defined windows of the life cycle. Bloodstream
forms in the mammalian host are covered by a uniform coat
consisting of one type of variant surface glycoprotein (VSG) at a
time. This protects the parasite from destruction by the host innate
immune system and allows it to evade the adaptive immune
response by periodically switching to a new VSG, a process known
as antigenic variation. In the midgut of the tsetse vector, as the
parasite differentiates to the procyclic form, it replaces the VSG
coat by GPI-anchored proteins known collectively as procyclins.
These proteins are characterised by internal dipeptide (EP)
or peptapeptide (GPEET) repeats. GPEET procyclin is the
major component of the coat during the first few days of infection
(early procyclic forms), but is replaced by EP procyclins as
the trypanosome differentiates to the late procyclic form [1].
Epimastigote forms in the salivary glands have a stage-specific coat
consisting of brucei alanine-rich proteins (BARP) [2], while
metacyclic forms, which are infectious for a new mammalian
host, again have a VSG coat, but draw on a different and more
limited repertoire than bloodstream forms [3].
In recent years it has become apparent that the surface coats of
insect forms of T. brucei and T. congolense are more similar than was
previously supposed. Midgut forms of T. congolense express
procyclins with characteristic heptapeptide (EPGENGT) repeats
[4], while epimastigotes express glutamic acid/alanine-rich
proteins [5,6] that are related to T. brucei BARPs. Two additional
surface molecules have been identified in T. congolense, a protease-
resistant surface molecule [7] that is expressed by early procyclic
forms and a newly discovered GPI-anchored protein, congolense
epimastigote-specific protein (CESP) [8]. Genes encoding proteins
related to CESP are also found in T. brucei (Tb927.8.930, 950 and
970). Epimastigote forms of the two species exhibit different tissue
tropisms in the fly, with T. brucei colonising the salivary glands and
T. congolense colonising the proboscis. At present it is not known
which parasite molecules determine this.
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The abundance of the major surface molecules has impeded the
identification of other membrane proteins, so that relatively little is
known about minor components of the parasite coat. Two families
of invariant surface proteins of unknown function, ISG65 and
ISG75, are expressed by bloodstream forms, but not by procyclic
forms [9]. Glycoconjugates on the surface of procyclic forms have
been described by Gu¨ther at al [10]. These are also found in cells
deficient in TbGPI12, implying that they do not possess GPI
anchors. Of the few membrane-associated proteins characterised
in procyclic forms, three are enzymes that modify the surface. Zinc
metalloproteases of the MSP-B family, which are expressed during
the differentiation of bloodstream to procyclic forms and in
established procyclic forms, are involved in VSG shedding [11]. In
procyclic forms, a trans-sialidase transfers sialic acid from
extracellular donor molecules to the GPI anchors [12,13]. Both
of these proteins are predicted to be GPI-anchored, but they are
likely to be of low abundance since they could not be detected by
biosynthetic labelling, even in cell lines devoid of procyclins
[14,15]. A membrane-associated kinase that phosphorylates
threonines in the pentapeptide repeat of GPEET is active in early
procyclic forms, but not in bloodstream forms, late procyclic forms
or epimastigotes [15,16]; neither the protein nor the gene has been
identified. Downstream of the procyclin genes, and forming part of
the same polycistronic transcription units, are several procyclin-
associated genes that are also stage-regulated, with increased levels
of mRNA in procyclic forms [17,18]. All of these potentially
encode secreted or membrane proteins, but as yet there is no
evidence that the proteins are produced, and none of the genes is
essential for transmission through tsetse [19].
Sixteen years ago, COS cell expression cloning combined with
antibody panning was used to identify surface molecules of
procyclic forms [20]. Of the two cDNA clones that were isolated,
one encoded EP1 procyclin, confirming the validity of the
approach. The other clone, PSSA-2, was predicted to encode a
membrane-spanning protein with a C-terminal domain consisting
of degenerate proline- and tyrosine-rich repeats. PSSA-2 mRNA
was more abundant in procyclic forms, suggesting that it might be
stage-regulated, but there was no information on the expression of
the protein. Here we demonstrate that the localisation and
topology of PSSA-2 are as postulated, and that the cytoplasmic tail
is required for correct targeting of the protein. PSSA-2 null
mutants have no perceptible phenotype in culture, but are
compromised in their ability to produce mature infections in tsetse.
Results
PSSA-2 is localised on the surface of procyclic forms
PSSA-2 is encoded by a single copy gene in T. brucei
(Tb10.26.0790) and shares 64% identity to a protein in T. congolense
and 49% to a protein in T. vivax. Amplification of the coding region
of PSSA-2 from T. brucei AnTat 1.1 revealed small differences to the
sequence in GeneDB, the most prominent of which was an insertion
of 30 base pairs encoding an additional tyrosine/proline-rich repeat.
PSSA-2 was previously predicted to consist of an N-terminal
extracellular domain, a single membrane-spanning domain and a
C-terminal cytoplasmic domain containing several copies of a
YGQP motif [20]. To analyse this, we first attempted to produce
antisera against different domains of PSSA-2, expressed as bacterial
fusion proteins. Although these antisera recognised the recombinant
protein moieties, they did not bind procyclic forms in IFA or
recognise a protein on immunoblots (data not shown). We therefore
used green fluorescent protein (GFP) or a haemagglutinin (HA) tag
to localise two versions of the protein, a full-length form and a
truncated form (D292–436PSSA-2) that lacked the predicted cyto-
plasmic domain (Fig. 1). Western blot analysis of stable transfor-
mants expressing the HA-tagged full length and truncated proteins
detected bands of 50 kDa and 35 kDa, respectively, consistent with
the predicted sizes of the polypeptides (Fig. 1B). In cells in which the
full-length protein was tagged at the C terminus, PSSA-2 was
detected on the surface, colocalising with GPEET (Fig. 1C).
Detection of the HA tag required permeabilisation of the cells with
Triton X-100, indicating that the C-terminal of the protein was
indeed cytoplasmic as predicted. In contrast, the truncated version
was retained in the endoplasmic reticulum, colocalising with BiP
(Fig. 1C). Replacing GFP by an HA tag did not alter the localisation
(data not shown). These results indicate that the cytoplasmic tail is
required for correct targeting to the plasma membrane.
Expression of PSSA-2 during the trypanosome life cycle
The original publication on PSSA-2 demonstrated that the
messenger RNA was more abundant in procyclic forms than in
bloodstream forms [20]. To analyse the developmental regula-
tion in more detail, RNA was isolated during the first 24 h of
synchronised differentiation from stumpy bloodstream forms
to procyclic forms. Northern blot analysis with probes for
PSSA-2 and EP procyclin (Fig. 2A) revealed that the transcripts
accumulated with the same kinetics, peaking ,4 h after
differentiation was triggered and then declining in established
procyclic forms. No differences in PSSA-2 mRNA levels were
observed when early and late procyclic forms were compared
(Fig. 2A, lanes +G and 2G, respectively). To monitor the kinetics
of protein expression, we used the PSSA-2-HA cell line described
above, in which the tagged copy of the coding region is followed
by the PSSA-2 39 untranslated region (UTR) and intergenic
region. Immunofluorescence analysis using anti-EP procyclin and
anti-HA antibodies showed that neither protein was expressed by
bloodstream forms (Fig. 2B). Three hours after being triggered to
differentiate, two populations were observed: cells that were
positive for both EP and PSSA-2, and cells that were negative for
both proteins. From 6 h onwards, all cells were double-positive.
Untranslated regions can be fused to reporter genes in order to
investigate expression in life cycle stages that cannot be cultured
(e.g. epimastigote forms). In the constructs routinely used in our
laboratory, transcription is driven by the procyclin promoter; this
results in robust expression that does not interfere with regulation
by the 39 UTR, as was previously demonstrated for BARP [2]. In
initial experiments, trypanosomes were stably transformed with
the coding region for dsRED, followed by the 39 UTR and
intergenic region of PSSA-2. One clone was used to infect tsetse
and monitored at various time points up to the production of
metacyclic forms. In these experiments, all life cycle stages in the
insect, with the exception of metacyclic forms, showed strong
fluorescence (data not shown). This gave us the first indication that
the protein might be widely expressed throughout the life cycle.
The negative result obtained with metacyclic forms must be
treated with caution, as there are indirect indications that genes
under the control of procyclin promoters may not be active in this
stage (C. Fragoso, unpublished data)[21].
In addition to the UTRs, it is known that coding regions can
provide an additional layer of regulation. This was previously
observed for the procyclin transcripts that are present in salivary
gland trypanosomes, but apparently not translated [21]. To take
this into account we used the PSSA-2-HA cell line described above
to infect tsetse. When flies were dissected 28–35 days post
infection, all cells in the midgut and foregut were positive for
PSSA-2, as were epimastigotes in saliva probes (Fig. 3). Once
again, metacyclic forms were negative.
Role of PSSA-2 in T. brucei
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A PSSA-2 null mutant shows reduced maturation of
infections
Since PSSA-2 appears to be expressed during a large part of the
trypanosome life cycle in the fly, and is at the interface between the
trypanosome and its environment, we determined whether it was
possible to generate a null mutant in procyclic forms. This was
readily achieved in two rounds of transformation in which the
PSSA-2 coding region was replaced by two selectable markers.
When monitored for growth, the null mutant grew at the same
rate as the wild type (see below).
To establish the role of PSSA-2 in transmission, teneral flies
were infected with procyclic forms of Antat 1.1 or the PSSA-2 null
mutant. Flies were dissected 28–35 days post infection and graded
for the prevalence and intensity of infections. Both the wild type
and the null mutant were capable of establishing midgut infections
with the same efficiency (Fig. 4) and no significant differences were
observed in their ability to produce heavy infections. In contrast,
the null mutant gave rise to fewer, and much weaker, salivary
gland infections than the wild type. The combined data from 4
independent experiments gave, on average, a 5-fold reduction in
prevalence compared to the wild type. These differences are
statistically significant (two-tailed paired Students T test,
p,0.005). To be sure that the decreased prevalence of salivary
gland infections was caused by the lack of PSSA-2, rather than a
secondary mutation elsewhere in the genome, an ectopic copy was
integrated upstream of the procyclin locus on one copy of
chromosome 10 (Supplemental Figure S1a). This copy was in the
same context as the HA-tagged copies described above (flanked by
a EP1 promoter/59 UTR and the PSSA-2 39UTR/intergenic
region), but was not modified by an epitope tag. Two independent
clones were characterised by Northern blot analysis and shown to
express 3.4-fold and 7.8-fold more PSSA-2 mRNA, respectively,
than wild type AnTat 1.1 procyclic forms (Supplemental Figure
S1b). When compared with the wild type for their ability to
establish midgut and salivary gland infections, there were no
significant differences in the prevalence of infections in both
compartments (Fig. 4). However, most of the salivary gland
infections by the addbacks were of intermediate intensity,
compared to the preponderance of heavy infections by the wild
type. When all infections were taken into account, the two
addback clones gave transmission indices of 35.8% and 35.1%,
respectively, compared to 23.3% by the wild type. This was
reduced to 22.6% and 26.3% if only heavy and intermediate
infections were taken into account. In summary, these data
confirm that PSSA-2 is required for efficient maturation of salivary
gland infections.
Post-translational modification of PSSA-2
The PSSA-2 polypeptide contains a potential N-linked glyco-
sylation site in the extracellular domain. To test if the protein was
Figure 1. PSSA-2 requires the cytoplasmic tail for surface localisation. A. Schematic representation of PSSA-2. Predicted structural domains
and signal peptide are indicated (not drawn to scale). AnTat 1.1 encodes a polypeptide of 436 amino acids, whereas the genome strain TREU 927/4
encodes a polypeptide of 425 amino acids. The sequence corresponding to the transmembrane domain is underlined; threonine residue T305 is in
boldface type and underlined. B. Immunoblot analysis of total lysates from procyclic forms of AnTat 1.1 stably transfected with plasmids encoding
either an HA-tagged version of truncated PSSA-2 (DPSSA-2), lacking the cytoplasmic domain from residues 292–436, or full-length PSSA-2. Proteins
were detected with an anti-HA antibody. 106 cell equivalents were loaded per lane. Markers are indicated on the left. C. Immunofluorescence analysis
of HA-tagged full length PSSA-2 (top panel) and a DPSSA-2/GFP fusion protein (lower panel). Trypanosomes were fixed with formaldehyde and
glutaraldehyde, permeabilized with Triton X-100 and stained with anti-GPEET, anti-HA or anti-BiP antibodies as indicated.
doi:10.1371/journal.pone.0007074.g001
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modified by carbohydrates, total lysates from cells expressing HA-
tagged full length PSSA-2 were treated with PNGase and
subsequently analysed on immunoblots. No difference in mobility
was detected after treatment, suggesting that PSSA-2 is not N-
glycosylated (Fig. 5A). The positive control, EP procyclin, showed
a decrease in Mr confirming that the PNGase was active.
The primary sequence of PSSA-2 is rich in tyrosine, threonine
and serine, and several of these amino acids are predicted to be
phosphorylated. To test this, total lysates were treated with l
Figure 2. Detection of PSSA-2 and procyclin during synchro-
nous differentiation of stumpy bloodstream forms to procyclic
forms. A. Northern blot analysis of wild type AnTat 1.1. Numbers
denote hours after triggering differentiation. +G: early procyclic forms
cultured in the presence of glycerol. 2G: late procyclic forms cultured
without glycerol. EtBr: ethidium bromide-stained rRNA is shown as a
loading control. B. Immunofluorescence analysis of cells expressing HA-
tagged PSSA-2 during differentiation from bloodstream forms to
procyclic forms. At given time points after differentiation was triggered,
cells were fixed and stained with DAPI (left panels), anti-HA to detect
PSSA-2 (central panels) and anti-EP (right panels).
doi:10.1371/journal.pone.0007074.g002
Figure 3. Expression of PSSA-2 in tsetse-derived trypano-
somes. Immunofluorescence analysis of PSSA-2-HA expression by
trypanosomes isolated from the midgut, foregut and saliva probes 28–
35 days after the infective bloodmeal. Trypanosomes were fixed with
formaldehyde and glutaraldehyde and stained with anti-HA antibody
(upper panel) and DAPI (lower panel).
doi:10.1371/journal.pone.0007074.g003
Figure 4. PSSA-2 does not influence midgut infections in
tsetse, but is required for efficient colonisation of the salivary
glands. Teneral flies were infected with procyclic forms of AnTat 1.1
(wild type), the PSSA-2 null mutant (PSSA-2 KO) or the independent
addback clones 1 and 2. Flies were dissected 28–35 days post infection
and graded for the prevalence and intensity of infections in the midgut
and salivary glands. The y-axis represents the percentage of infected
flies. The total number of flies is indicated above the bars on the graphs.
For the panel on the left, this represents the total numbers from 4
independent experiments. Transmission index (see text) is the
percentage of midgut infections giving rise to salivary gland infections.
doi:10.1371/journal.pone.0007074.g004
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phosphatase, which is capable of removing phosphate groups from
all three amino acids (Fig. 5B). Antibodies that discriminate
between phosphorylated and non-phosphorylated forms of
GPEET were used as a positive control. Although l phosphatase
treatment did not alter the mobility of PSSA-2, phosphorylation of
the protein could not be excluded. In a further step, PSSA-2-HA
was immunoprecipitated and probed with antibodies against
phosphotyrosine (anti-pY) and phosphothreonine-proline (anti-
pTP; Fig. 5C). PSSA-2-HA could be detected with anti-pTP, and
reactivity was lost after treatment with l phosphatase (Fig. 5C).
Thr305 is phosphorylated and depends on a MAP kinase
The primary sequence of PSSA-2 contains a single threonine (T305)
followed by a proline residue. To confirm that this residue was
phosphorylated, site-directed mutatgenesis was performed on PSSA-
2-HA and the mutants were used to stably transform AnTat 1.1.
Mutation of T305 to alanine abolished reactivity with anti-pTP
(Fig. 6A) and resulted in increased migration on SDS-polyacrylamide
gels (Fig. 6B). In contrast, mutation of T305 to aspartate, which should
mimic phosphorylation, did not alter the mobility of the protein
(Fig. 6B). Neither mutation had an effect on the localisation of the
protein (Fig. 6C). Since treatment with l phosphatase did not change
the mobility of PSSA-2, this suggests that T305 might be required in
order for other modifications to take place.
The amino acid sequence flanking T305 (DPDT305PQ) is a
PXS/TP motif, known to be a consensus motif for MAP kinase
phosphorylation. Two MAP kinase null mutants were recently
generated in our laboratory [22,23]. Procyclic forms of a MAPK4
Figure 5. Post-translational modification of PSSA-2. A. Total
lysates from procyclic forms stably expressing HA-tagged PSSA-2 were
incubated in the presence (+) or absence (2) of PNGase and analysed
by immunoblotting. Top panel: PSSA-2 detected with anti-HA ; lower
panel, anti-EP. B. Total lysates from procyclic forms stably expressing
HA-tagged PSSA-2 were incubated in the presence (+) or absence (2) of
l phosphatase and analysed by immunoblotting. MAb 5H3 (second
panel) preferentially binds phosphorylated GPEET [37]. C. HA-tagged
PSSA-2 was immunoprecipitated, incubated with (+) or without (2) l
phosphatase and detected with antibodies against phosphotyrosine
(phosphoY; upper panel) or phosphothreonine-proline (phospho-TP;
lower panel).
doi:10.1371/journal.pone.0007074.g005
Figure 6. Confirmation that T305 is phosphorylated. A. HA-
tagged PSSA-2 or PSSA-2(T305A) were immunoprecipated, incubated in
the presence (+) or absence (2) of l phosphatase and analysed by
immunoblotting with antibodies against phospho-TP (upper panel) or
anti-HA, to detect PSSA-2 (lower panel). B. Mutation of T305 to alanine
alters the electrophoretic mobility of the protein. Total lysates from cells
stably expressing PSSA-2(T305), PSSA-2(T305A) or PSSA-2(T305D) were
detected with anti-HA antibodies. 1.56105 cell equivalents were loaded
in the first two lanes and 36106 for PSSA-2(T305A), which is much more
weakly expressed. C. PSSA-2(T305A) and PSSA-2(T305D) localise to the
plasma membrane. Cells were fixed and permeablised as described in
the legend to Figure 1. D. MAP kinase 4 is required for phosphorylation
of T305. Null mutants of MAPK4 (MAPK4 KO) [23] and MAPK5 (MAPK5
KO) [22] were stably transformed with HA-tagged PSSA-2. The protein
was immunoprecipated and detected with anti-phospho-TP antibodies
to detect phospho-T305 or anti-HA to detect PSSA-2.
doi:10.1371/journal.pone.0007074.g006
Role of PSSA-2 in T. brucei
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knockout are sensitive to temperature stress [23]. Long slender
bloodstream forms of the MAPK5 knockout differentiate more
readily to stumpy forms, but no phenotype was detected in
procyclic forms [22]. To test if phosphorylation of T305 is
dependent on either of these kinases, MAPK4 and MAPK5 null
mutants were stably transformed with PSSA-2-HA. The protein
was immunoprecipitated with anti-HA matrix and probed with
anti-HA and anti-pTP antibodies (Fig. 6D). When compared to
expression in wild type cells, T305 was still phosphorylated by the
MAPK5 null mutant and migrated with the same mobility. In
contrast, when the protein was expressed in MAPK4-deficient
cells, T305 was not phosphorylated. Furthermore, the anti-HA
antibodies detected a doublet that migrated more slowly on
polyacrylamide gels, again suggestive of altered post-translational
modifications. These modifications must differ, however, from
those that occur when T305 is mutated to alanine (compare Fig. 6B,
lane T305A with Fig. 6D, lane MAPK4 KO).
Localisation of PSSA-2 depends on T305 and genetic
background
With the aim of investigating the role of T305 in vivo, we used the
PSSA-2 null mutant to create a series of addbacks. In contrast to
the addbacks used for the transmission experiments shown in
Figure 4, these were tagged with a C-terminal HA epitope in order
to detect the protein. The T305 addback (equivalent to PSSA-2-
HA) and the T305D mutant both localised to the plasma
membrane (Fig. 7). In contrast to what was observed in the wild
type background, however, (Fig. 6C), the T305A variant did not
show surface staining in the majority of cells (Fig. 7 and
Supplemental Fig. S2) and, once again, was expressed at lower
levels than the other two versions (see legend to Fig. 6B). The
mislocalisation did not seem to be harmful, because this clone
grew at the same rate as the wild type and the null mutant
(doubling times 15.7–16.8 h; Fig. 8). The T305 addback also had
no effect on growth. We observed, however, that the T305D
mutation slowed growth of the cells, and that this was more
pronounced in the addback, which lacked endogenous PSSA-2
(doubling time 38.7 h), than when it was expressed in a wild type
background (doubling time 25.3 h). Taken together, these results
suggest that T305 plays a role in determining the localisation of
PSSA-2 and that a mutation mimicking constitutive phosphory-
lation might be acting as a dominant negative mutant. However,
given that both mutations already affect the normal function of the
protein in procyclic culture forms, we did not test them further in
tsetse.
Discussion
In this study we have demonstrated that PSSA-2 is a surface
protein of insect forms of T. brucei with an extracellular N-terminal
domain and a cytoplasmic C-terminal domain as predicted by
Jackson and coworkers sixteen years ago [20]. Single transmem-
brane-spanning surface proteins, exemplified by ISG65 and ISG75
[24], have been identified in bloodstream forms, but this is the first
example in insect forms. Such proteins could potentially interact with
external factors and transduce signals to the parasite’s interior, which
was the original rationale for comparing full length and truncated
PSSA-2. No conclusions could be drawn from this experiment,
however, as removing the C-terminal domain resulted in retention of
the protein in the endoplasmic reticulum. This indicates that the
cytoplasmic tail contains signals for forward trafficking of the protein
to the plasma membrane. In this respect PSSA-2 resembles ISG65
and CRAM, both of which require the cytoplasmic domain in order
to exit from the endoplasmic reticulum [25,26].
PSSA-2 is not expressed by bloodstream forms, but could be
detected in all life cycle stages in tsetse apart from metacyclic
forms. Thus, it differs from the major surface proteins, which show
a more restricted expression pattern. Deletion of PSSA-2 had no
effect on midgut infections, but resulted in a decrease in both the
prevalence and intensity of salivary gland infections, a phenotype
similar to the one obtained with a procyclin null mutant [15]. Re-
expression of PSSA-2 restored the ability of parasites to colonise
the salivary glands and produce metacyclic forms, although there
was a shift towards infections of intermediate, rather than heavy
intensity. When weak salivary gland infections were also taken into
account, the two PSSA-2 addback mutants completed the life cycle
slightly more efficiently than the wild type. Data on the number of
metacyclic forms required to initiate an infection in mammals are
scant, although experiments performed on humans bitten by tsetse
suggested that several hundred parasites were needed to infect an
‘‘average man’’ [27]. This figure may well be an overestimate,
however, since the trypanosomes were passaged in animals and
some of them could have lost the property of human serum-
resistance. We have observed that flies with weak salivary gland
infections can readily transmit parasites to mice ([15] and the
Figure 7. Surface localisation of PSSA-2(T305A) depends on the
genetic background. HA-tagged wild type PSSA-2(T305) or the
mutant forms T305A or T305D were expressed in a PSSA-2 null mutant.
Left panel, phase contrast; right panel, detection of PSSA-2 with anti-HA
antibodies/DAPI staining of DNA. Cells were fixed and permeablised as
described in the legend to Figure 1.
doi:10.1371/journal.pone.0007074.g007
Role of PSSA-2 in T. brucei
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PSSA-2 null mutants in this study), and it has been documented
that a single fly bite is sufficient to infect a vervet monkey, even
when metacyclic forms are not detectable in saliva [28].
PSSA-2 is rich in serine, threonine and tyrosine and has the
potential to be highly modified, but no changes in electrophoretic
mobility were observed when the protein was treated with l
phosphatase. In addition, no reactivity was detected with anti-
phosphotyrosine, anti-sulphotyrosine or anti-OGlcNAc antibodies.
One threonine residue (T305) in the cytoplasmic domain is
phosphorylated, however. Mutation of T305 to alanine increased
the electrophoretic mobility of the protein, indicating that it was
aberrantly processed. In contrast, mutation of T305 to aspartic acid
(which would mimic phosphorylation) had no effect on mobility.
Taken together, this suggests that phosphorylation of T305 might be
a prerequisite for further modifications. Phosphorylation of T305
was shown to depend on MAPK4, a kinase that was previously
shown to protect procyclic forms against elevated temperatures
[23]. Although T305 occurs in a context that makes it a possible
substrate for a MAP kinase, it is not known if MAPK4 modifies it
directly. Interestingly, PSSA-2 derived from cells deficient in
MAPK4 migrated more slowly than PSSA-2 from wild type cells,
suggesting alterations in post-translational modifications that
differed from those described above. At present, the nature of all
these modifications is unknown. There are two possible interpre-
tations of these results. One possibility is that modifying enzymes in
the cell can discriminate between threonine, phosphothreonine and
alanine at this position. Additionally, MAPK4 may be required for
the activity of auxiliary factors that are involved in post-translational
modifications.
Deletion of the PSSA-2 gene had no discernible effect on the
growth or morphology of procyclic forms in culture. Because of
the dependence on MAPK4 for phosphorylation of T305, we also
tested if the null mutant was temperature sensitive, but this was not
the case (data not shown). Derivatives of the null mutant
complemented with wild type PSSA-2 or PSSA-2(T305D) ex-
pressed the protein on the surface. This contrasted with PSSA-
2(T305A), which was largely internal in the null mutant
background, although it was expressed on the surface of wild
type cells. These differences can be explained best by a model in
which PSSA-2 forms homodimers or multimers. We postulate that
in normal procyclic forms the association of a mutant polypeptide
with a wild-type copy of PSSA-2 would be sufficient to transport it
to the surface. In the absence of wild type PSSA-2, these mutant
forms might not be able to interact efficiently with factors involved
in cargo export from the endoplasmic reticulum or retention at the
surface. The T305D mutant is not subject to these constraints,
suggesting that aspartic acid functionally substitutes for phospho-
threonine. There are several cysteine residues in PSSA-2,
including one close to the C-terminal. If this particular cysteine
residue is required for dimer formation, it could also explain why
the truncated version is not exported to the surface since it would
be unable to form disulphide bridges with full-length molecules.
Although the T305D mutant localised correctly in both wild type
and null mutant backgrounds, its expression slowed growth in both
contexts. This effect was more pronounced in the null mutant
background. Since cells grow normally without PSSA-2, one
possibility is that the mutant protein, by mimicking permanently
phosphorylated T305, sequesters factors away from wild type
PSSA-2 and/or other molecules that are required for cell cycle
progression.
In conclusion, PSSA-2 is the latest addition to a growing
catalogue of surface molecules expressed by trypanosomes in their
insect vector. Although it is a minor component of the coat
compared to GPI-anchored proteins such as the procyclins, it has
a clear role in the maturation of infection. Because of its structure,
with a single membrane-spanning domain, PSSA-2 could
potentially sense and transmit signals from the fly to the parasite
and vice versa. It is also possible that the phosphorylation status of
the protein, and its dependence on at least one MAP kinase, might
contribute to the parasite’s decision to proliferate, differentiate or
migrate.
Materials and Methods
Trypanosomes
Procyclic forms of T. brucei AnTat 1.1 [29,30] and genetically
manipulated derivatives of it were cultured in semi-defined
medium (SDM-79) [31,32] supplemented with 10% heat-inacti-
vated fetal bovine serum (FBS) at 27uC. Removing glycerol from
the medium allows differentiation from early to late procyclic
forms [1]. The MAPK4 and MAPK5 null mutants have been
described previously [22,23]. Bloodstream forms of AnTat 1.1
were isolated from mouse blood as described [15].
Stable transformation of procyclic form trypanosomes was
performed as described previously [1] except that cytomix
(120 mM KCl, 0.15 mM CaCl2, 10 mM K2HPO4 pH 7.6,
25 mM HEPES pH 7.6, 2 mM EDTA, 5 mM MgCl2) was used
as the electroporation buffer. The following concentrations of
antibiotics were used for selection of stable transformants: G418
25 mg ml21, puromycin 1 mg ml21 and phleomycin 2.5 mg ml21.
Figure 8. Mutation of T305 to aspartic acid has a deleterious
effect on growth. Comparison of the population doubling time of
wild type AnTat 1.1 with various PSSA-2 mutants. Cell densities were
adjusted daily to 26106 cells ml21 in order to ensure logarithmic
growth. Generation times are shown in square brackets.
doi:10.1371/journal.pone.0007074.g008
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To monitor generation times, cultures were propagated in
SDM-79 supplemented with 10% FBS and 20 mM glycerol. The
experiment was initiated with 26106 cells ml21. Cells were
counted every 24 hours and were kept in logarithmic growth by
diluting them every day to 26106 ml21.
In vitro differentiation
Bloodstream form trypanosomes were resuspended at a density
of 1–26106 cells ml21 in SDM-79 supplemented with 10% FBS
and 20 mM glycerol. Cells were triggered to differentiate by
adding 6 mM cis-aconitate to the culture medium and incubation
at 27uC [33].
Isolation of total RNA from trypanosomes and Northern
blot analysis
Total RNA extraction using the hot phenol method and
Northern blot analysis were performed by standard procedures
[34]. Ten micrograms of total RNA were loaded per lane. Blots
were hybridised with probes corresponding to the coding regions
of PSSA-2 or EP1. Radioactively labeled probes were generated
using a Megaprime DNA labelling system (Amersham Biosciences,
Buckinghamshire, UK) according to manufacturer’s instructions.
Blots were hybridised and washed under stringent conditions.
Immunofluorescence analysis (IFA)
Cells were fixed for 15 minutes at room temperature in PBS
containing 4% formaldehyde and 0.1% glutaraldehyde. After
fixation, cells were permeabilised by adding 0.2% (v/v) Triton
X-100. Unspecific antibody binding sites were blocked with PBS
containing 2% (w/v) BSA. Fly-derived trypanosomes were fixed as
described, with the exception that the cells were first air dried onto
microscope slides and the permeabilisation step was omitted.
The HA epitope was detected with sc-805 (Santa Cruz
Biotechnology, Santa Cruz, USA) diluted 1:250 or 3F10 (Roche
Applied Science, Basel, Switzerland) diluted 1:500. For detection of
EP and GPEET procyclins, the antibodies TRBP1/247 anti-EP
[35,36] and 5H3 anti-GPEET [37], gifts from Terry Pearson,
University of Victoria, were diluted 1:500. Anti-BiP antibody, kindly
provided by Jay Bangs, University of Wisconsin, was diluted 1:400.
The secondary antibodies anti-rabbit Alexafluor 568, anti-
rabbit Alexafluor 488 and anti-mouse Alexafluor 488 (Molecular
Probes, Eugene, OR) were diluted 1:1000. Samples were analysed
with a Nikon Eclipse E600 microscope connected to a Nikon
DXM1200 CCD camera or with a Leica DM IRE2 inverted
microscope connected to a Leica True Confocal Scanner.
Cyclical transmission through tsetse flies
Pupae of Glossina morsitans morsitans were obtained from the
Department of Entomology, Slovak Academy of Science,
Bratislava. Transmission experiments were performed at the Swiss
Tropical Institute, Basel, as described previously [38]. Flies were
dissected 28–35 days after the infective blood meal, and midguts
and salivary glands were analysed for the presence of trypano-
somes. Infections were graded according to Ruepp et al. [38]. To
complete the life cycle, salivary glands of flies with mature
infections were injected intraperitoneally into mice.
Constructs to generate GFP- and HA-tagged forms of
PSSA-2
In order to amplify the full length and the truncated versions of
PSSA-2, the A/C and A/B primer pairs were used respectively.
The PCR was performed using genomic DNA from T. brucei
AnTat1.1 as the template.
PSSA-2H (A): ACAAGCTTATGGCATCGAACAGCTC
PSSA-2SSII (B): TAGTCGACCATTGGATGAAGAGCC
PSSA-2SFII (C): TTGTCGACCTGTAGGATTTGGTTG
The restrictions sites used in cloning are underlined.
The coding sequences were cloned upstream of the coding
sequence of a green fluorescent protein in pG-EGFPb-DLII [39]
via the HindIII and SalI restriction sites, giving the plasmids
pG-PSSA-2-EGFPb-DII and pG-D292–436PSSA-2-EGFPb-DII. In
order to replace the 39 UTR from pG-PSSA-2-EGFPb-DII and
pG-D292–436PSSA-2-EGFPb-DII, the 39 UTR/intergenic region of
PSSA-2 was amplified by PCR using genomic DNA from T. brucei
AnTat 1.1 with the following primers PSSA-2interB and PSSA-
2interX (see following section).
The vectors and the PCR product were digested with BamHI
and XbaI, and the 39UTR sequences replaced, giving rise to pG-
PSSA-2-EGFPb-39UTRPSSA-2 and pG-D292–436PSSA-2-EGFPb-
39UTRPSSA-2.
To replace the GFP coding sequence with a haemagglutinin (HA)
tag, the GFP sequence was released from pG-PSSA-2-EGFPb-
39UTRPSSA-2 and pG-D292–436PSSA-2-EGFPb-39UTRPSSA-2
with SalI and BamHI. The plasmids were repaired with Klenow to
create blunt ends. Complementary primers for HA epitope tagging
(HA-tag5-3/HA-tag3-5) were annealed then cloned into the
prepared vectors.
HA-tag5-3: TACCCTTATGACGTACCAGACTATGCAG-
AAGGACGTGAACCT
HA-tag3-5: AGGTTCACGTCCTTCTGCATAGTCTGGT-
ACGTCATAAGGGTA
The resulting clones were screened for inserts with the correct
orientation and verified by sequencing. D292–436PSSA-2-HA
contains a single HA tag while the full length PSSA-2-HA
contains two copies of the tag.
PSSA-2 null mutants and addbacks
To generate null mutants by homologous recombination, two
targeting constructs were created: pPSSA-2-KO-neo and pPSSA-
2-KO-phleo. In both vectors, the antibiotic resistance genes were
cloned between the 59 and 39 flanking regions of PSSA-2. The
flanking sequences were amplified by PCR from AnTat1.1
genomic DNA using the following oligonucleotides:
PSSA-2interH: AGAAGCTTTTCCTTGCGACGGCGTTA
PSSA-2interK: ACGGTACCGGGAGATTGGATACGATG
PSSA-2interB: ATGGATCCTTAACGCGGTTAGGATAG
PSSA-2interX: CCTCTAGAGTCCTTTACCTTGTCAAC
The restrictions sites used in cloning are underlined.
The 59 region was amplified with the primer pair PSSA-
2interK/PSSA-2interH and the 39 region was amplified with the
primer pair PSSA-2interB/PSSA-2interX.
For stable transfections, plasmids were cleaved with KpnI and
XbaI. To obtain a null mutant, cells were submitted to two rounds
of transfection.
A construct encoding an untagged version of PSSA-2 was
generated from pG-PSSA-2-EGFPb-39UTRPSSA-2 in two steps.
In a first step, the neomycin-resistance gene was replaced by
puromycin-resistance [38]. In a second step, the open reading frame
for PSSA-2-EGFP was replaced by a PCR product generated using
the oligonucleotides PSSA-2H (see section below) and revPSSA2-
stop (TTGTCGACCTACACTGTAGGATTTGG).
Site-directed mutagenesis
To mutate thr305 (T305) in PSSA-2-HA to alanine (pG-T305A/
PSSA-2-HA-39UTRPSSA-2) or aspartic acid (pG-T305D/PSSA-2-
HA-39UTRPSSA-2), we designed primers containing mutated
codons. The triplet corresponding to T305 ACA was mutated to a
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GCA triplet coding for alanine or to a GAT triplet coding for
aspartic acid.
Complementary primers were used in two separate PCRs with
an outer flanking primer, in order to amplify the two halves of
PSSA-2. E/B* and A*/F primer pairs were used to mutate
threonine to alanine. The threonine to aspartic acid mutation was
generated with E/D and C*/F primer pairs. The two PCR
products were combined as a template for the second PCR, which
was done using the outer flanking primers (E/F).
Complementary overlapping mutagenic primers:
PSSA-2.thr-ala.fw (A*): GATCCTGATGCACCTCAGGGG-
GATGG
PSSA-2.thr-ala.rv (B*): CCATCCCCCTGAGGTGCATCAG-
GATC
PSSA-2.thr-asp.fw (C*): GATCCTGATGATCCTCAGGGG-
GATGG
PSSA-2.thr-asp.rv (D): CCATCCCCCTGAGGATCATCAG-
GATC
The mutated codons are shown in boldface type.
Outer flanking primers:
PSSA-2H (E): ACAAGCTTATGGCATCGAACAGCTC
PSSA-2interX (F): CCTCTAGAGTCCTTTACCTTGTCAAC
The restrictions sites used in cloning are underlined.
The mutated sequences created by PCR were used to replace the
wild type sequence in the plasmid pG-PSSA-2-HA-39UTRPSSA-2.
All constructs were sequenced before being used for transfection.
For stable transformations, plasmids were cleaved with SpeI in order
to integrate the plasmid upstream of a procyclin locus. Transfor-
mants were selected with G418 as above. Introduction of an ectopic
copy of PSSA-2 into the null mutant was achieved by using modified
versions of the plasmids described above, in which the neomycin
resistance gene was replaced by puromycin. For stable transfections,
plasmids were cleaved with SpeI.
Immunoprecipitation and immunoblot analysis
For each immunoprecipitation 1–26108 cells were harvested by
centrifugation at 1300 g, 10 minutes at 4uC. Cells were washed
once in cold PBS and the pellet resuspended in 1 ml of Lysis
Buffer (20 mM Tris-HCl pH 7.5, 2 mM EDTA, 2 mM EGTA,
1% (v/v) Triton X-100) supplemented with protease inhibitor
cocktail (Roche Applied Science) according to manufacturer’s
instructions. The suspension was passed through a 27G needle
three times, centrifuged at 16000 g for 10 minutes at 4uC and the
supernatants were transferred to fresh tubes. 20–25 ml of
haemagglutinin-tagged agarose beads (anti-HA affinity matrix,
Roche Applied Science) were washed twice in PBS and incubated
in Lysis Buffer, 2% (w/v) casein for 1 hour at room temperature
on an end-over-end rotating platform. The matrix was then
washed three times with Lysis Buffer and added to the
supernatants. Matrix and supernatants were incubated at room
temperature on a rotor for 2 hours, after which the matrix was
pelleted and washed four times in Lysis Buffer. The washed matrix
was then heated at 50uC for 5 minutes in 30 ml Laemmli Buffer
[40]. 10 ml aliquots were used for immunoblot analysis. Following
SDS-PAGE, samples were transferred to Immobilon-P (Millipore,
Bredford, MA, USA). Membranes were blocked with TBS
containing 0.05% (v/v) Tween20 2% (w/v) BSA followed by
overnight incubation at 4uC with the primary antibodies. The
following antibodies were used: anti-HA antibody (12CA5, Roche
Applied Science) diluted 1:1000; anti-phospho-threonine-proline
antibody (Cell Signaling, Beverly, MA, USA) diluted 1:500; anti-
phospho-tyrosine antibody (Cell Signaling) diluted 1:1000;
TRBP1/247 anti-EP antibody [35,36] diluted 1:2500; 5H3 anti-
GPEET antibody [37] diluted 1:1000. HRP-conjugated secondary
antibodies anti-mouse or anti-rabbit (DAKO, Glostrup, Denmark)
were usually diluted 1:3000, with the exceptions of anti-EP and
anti-GPEET where the secondary antibodies were diluted
1:10000. Membranes were exposed to Enhanced Chemilumines-
cent Substrate (Pierce Rockford, USA) and chemiluminescent
signals captured on X-ray film.
l PPase and PNGase F treatment
Both reactions were performed with kits from New England
BioLabs (Beverly, MA, USA). For l PPase treatment 1–26107
cells were pelleted and washed once in PBS, resuspended in 40 ml
of H2O, 5 ml of 106 lPPase Reaction Buffer and 5 ml of
106MnCl2 stock solution. After pre-incubation at 30uC for 30
minutes, 200 U of lPPase were added and the reaction incubated
for another 30 minutes. For PNGase F treatment, 1–26107 cells
were pelleted and washed once in PBS. Cells were resuspended in
36 ml of H2O and 4 ml of 106 Glycoprotein Denaturing Buffer
and boiled for 10 minutes. After cooling to room temperature, 5 ml
of 10% NP40, 5 ml of 106 G7 Reaction Buffer and 500 U of
PNGase were added and the lysates were incubated at 37uC for
2 hours. As negative controls, cells were treated in the same way
but lPPase or PNGase were omitted. An equal volume of H2O
was used as a replacement for the enzyme.
Supporting Information
Figure S1 Analysis of PSSA-2 addbacks
Found at: doi:10.1371/journal.pone.0007074.s001 (1.36 MB
DOC)
Figure S2 Localisation of PSSA-2 T305A in a null mutant
background
Found at: doi:10.1371/journal.pone.0007074.s002 (0.56 MB TIF)
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